To inhibit HCV replication, the infected hepatocytes were treated with increasing concentration of recombinant IFN-α (from 10 to 1000u/ml), and HCV replication of H77S.3 infection was monitored for 3 days (Fig 4A and S5 Fig). The gene discussed is IFNA2; the disease is infection.